Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
15.70
-0.72 (-4.38%)
At close: Dec 5, 2025, 4:00 PM EST
15.71
+0.01 (0.06%)
After-hours: Dec 5, 2025, 5:33 PM EST
COEP Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 0.5 | - | - | - | 0.08 | 0.03 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | 143.81% | 27.68% | Upgrade
|
| Cost of Revenue | 0.14 | - | - | - | - | 0.96 | Upgrade
|
| Gross Profit | 0.37 | - | - | - | 0.08 | -0.93 | Upgrade
|
| Selling, General & Admin | 9.97 | 5.62 | 13.35 | 34.18 | 14.12 | 5.78 | Upgrade
|
| Research & Development | 1.31 | 2.33 | 6.67 | 0.02 | - | 0 | Upgrade
|
| Amortization of Goodwill & Intangibles | 1 | 1 | 1 | - | - | - | Upgrade
|
| Operating Expenses | 13.58 | 10.05 | 21.49 | 34.2 | 14.12 | 5.78 | Upgrade
|
| Operating Income | -13.22 | -10.05 | -21.49 | -34.2 | -14.05 | -6.71 | Upgrade
|
| Interest Expense | -0.28 | -0.4 | -0.11 | -0.22 | -0.19 | -0.15 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.21 | -0.19 | 0.33 | 0.01 | 0.79 | -2.29 | Upgrade
|
| EBT Excluding Unusual Items | -13.29 | -10.64 | -21.27 | -34.41 | -13.45 | -9.16 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.04 | - | - | -0 | - | Upgrade
|
| Other Unusual Items | -0.2 | -0.2 | - | -3.17 | - | - | Upgrade
|
| Pretax Income | -13.67 | -10.88 | -21.27 | -37.57 | -13.45 | -9.16 | Upgrade
|
| Earnings From Continuing Operations | -13.67 | -10.88 | -21.27 | -37.57 | -13.45 | -9.16 | Upgrade
|
| Minority Interest in Earnings | 1.28 | 1.06 | - | - | - | - | Upgrade
|
| Net Income | -12.39 | -9.81 | -21.27 | -37.57 | -13.45 | -9.16 | Upgrade
|
| Net Income to Common | -12.39 | -9.81 | -21.27 | -37.57 | -13.45 | -9.16 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | -82.00% | 49.84% | 79.70% | 30.98% | 79.11% | 18.53% | Upgrade
|
| EPS (Basic) | -2.40 | -5.10 | -16.56 | -52.57 | -24.64 | -30.05 | Upgrade
|
| EPS (Diluted) | -2.40 | -5.10 | -16.56 | -52.57 | -24.64 | -30.05 | Upgrade
|
| Free Cash Flow | -8.35 | -6.65 | -7.24 | -3.88 | -4.49 | -3.14 | Upgrade
|
| Free Cash Flow Per Share | -1.62 | -3.46 | -5.64 | -5.42 | -8.23 | -10.29 | Upgrade
|
| Gross Margin | 72.96% | - | - | - | 100.00% | - | Upgrade
|
| Operating Margin | -2638.23% | - | - | - | -18727.91% | -21823.77% | Upgrade
|
| Profit Margin | -2472.91% | - | - | - | -17932.37% | -29765.89% | Upgrade
|
| Free Cash Flow Margin | -1667.01% | - | - | - | -5985.92% | -10195.12% | Upgrade
|
| EBITDA | -12.08 | -9.05 | -20.49 | -33.19 | -13.6 | -6.39 | Upgrade
|
| D&A For EBITDA | 1.14 | 1 | 1 | 1 | 0.45 | 0.32 | Upgrade
|
| EBIT | -13.22 | -10.05 | -21.49 | -34.2 | -14.05 | -6.71 | Upgrade
|
| Revenue as Reported | 0.5 | - | - | - | 0.08 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.